NZD 0.38
(2.7%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -27.28 Million | -7.06 Million | -2.91 Million | 16.21 Million | 6.06 Million | 5.62 Million |
Net Income | 4.64 Million | 10.73 Million | 2.24 Million | 1.72 Million | -21.45 Million | -16.78 Million |
Depreciation & Amortization | 1.94 Million | 1.83 Million | 1.63 Million | 913 Thousand | 4.46 Million | 3.47 Million |
Deferred income taxes | 174 Thousand | -44 Thousand | 200 Thousand | -132 Thousand | 4.81 Million | -399 Thousand |
Stock-based compensation | 117 Thousand | 202 Thousand | 362 Thousand | 51 Thousand | - | - |
Change in working capital | -10.48 Million | 10.54 Million | -7.18 Million | 16.29 Million | 8.88 Million | -1.04 Million |
Other non-cash items | -23.5 Million | -30.34 Million | -171 Thousand | -2.64 Million | 9.6 Million | 27.34 Million |
Investing Cash Flow | 23.46 Million | 30.07 Million | 5.04 Million | 22.56 Million | -2.09 Million | 8.78 Million |
Investments in PPE | -4.04 Million | -1.95 Million | -2.89 Million | -2.48 Million | -2.11 Million | -4.7 Million |
Acquisitions | - | 44 Thousand | 105 Thousand | 25.05 Million | 28 Thousand | 110 Thousand |
Investment purchases | -17 Million | -3.5 Million | -105 Thousand | -12 Million | - | -110 Thousand |
Sales/Maturities of investments | 19.5 Million | -3.5 Million | 8 Million | -25.05 Million | - | 10.59 Million |
Other Investing Activities | 25 Million | 38.99 Million | -55 Thousand | 37.05 Million | 28 Thousand | 2.89 Million |
Financing Cash Flow | -1.35 Million | -2.05 Million | -1.83 Million | -17.54 Million | -6.19 Million | -11 Million |
Debt repayment | -1.35 Million | -2.05 Million | -2.04 Million | -15.8 Million | -4.7 Million | -11 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 208 Thousand | - | - | - |
Other Financing Activities | -1.35 Million | -2.05 Million | -2.04 Million | -1.74 Million | -1.49 Million | -11 Million |
Accounts receivables | -704 Thousand | 2.39 Million | 100 Thousand | 132 Thousand | -263 Thousand | 511 Thousand |
Accounts payables | 1.4 Million | 2.73 Million | -856 Thousand | 2.44 Million | -6.4 Million | -2.06 Million |
Inventory | -8.22 Million | 6.14 Million | -7.22 Million | 12.04 Million | 15.33 Million | 1.53 Million |
Other working capital | -1.55 Million | -731 Thousand | 799 Thousand | 1.67 Million | 213 Thousand | -1.03 Million |
Cash at beginning of period | 31.81 Million | 10.87 Million | 10.5 Million | 1.27 Million | 2.72 Million | 2.11 Million |
Cash at end of period | 26.64 Million | 31.81 Million | 10.87 Million | 22.5 Million | 1.27 Million | 2.72 Million |
Capital Expenditure | -4.04 Million | -1.95 Million | -2.89 Million | -2.48 Million | -2.11 Million | -4.7 Million |
Effect of forex changes on cash | 5000.00 | -13 Thousand | 69 Thousand | -10 Thousand | 60 Thousand | -74 Thousand |
Net cash flow / Change in cash | -5.17 Million | 20.94 Million | 366 Thousand | 21.23 Million | -1.44 Million | 613 Thousand |
Free Cash Flow | -31.32 Million | -9.02 Million | -5.81 Million | 13.73 Million | 3.94 Million | 917 Thousand |
Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 3.16 Million | 4.64 Million | 3.16 Million | -1.67 Million | -838.5 Thousand | 10.73 Million |
Depreciation & Amortization | 521.49 Thousand | 1.94 Million | 521.49 Thousand | 897 Thousand | 448.5 Thousand | 1.83 Million |
Deferred income taxes | 171 Thousand | 174 Thousand | - | 3000.00 | - | -44 Thousand |
Stock-based compensation | 26.5 Thousand | - | 26.5 Thousand | 32 Thousand | 32 Thousand | 202 Thousand |
Change in working capital | -4.71 Million | -9.22 Million | -4.71 Million | -5.03 Million | -522.5 Thousand | 10.54 Million |
Other non-cash items | -4.71 Million | -13.46 Million | -4.71 Million | -3.61 Million | -7.04 Million | -30.34 Million |
Investing Cash Flow | 9.97 Million | 23.46 Million | 9.97 Million | 3.5 Million | 1.75 Million | 30.07 Million |
Investments in PPE | -1.02 Million | -4.04 Million | -1.02 Million | -1.99 Million | -996 Thousand | -1.95 Million |
Acquisitions | - | - | - | - | - | 44 Thousand |
Investment purchases | -12.5 Million | -17 Million | - | -4.5 Million | - | -3.5 Million |
Sales/Maturities of investments | 19.5 Million | 19.5 Million | - | - | - | -3.5 Million |
Other Investing Activities | 11 Million | 25 Million | 11 Million | 10 Million | 2.75 Million | 38.99 Million |
Financing Cash Flow | -361 Thousand | -1.35 Million | -361 Thousand | -636 Thousand | -318 Thousand | -2.05 Million |
Debt repayment | - | - | - | - | - | -2.05 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -361 Thousand | - | -361 Thousand | -318 Thousand | -318 Thousand | -2.05 Million |
Accounts receivables | -111 Thousand | -646 Thousand | -111 Thousand | -469 Thousand | -241 Thousand | 2.39 Million |
Accounts payables | 5.56 Million | 1.4 Million | - | -4.16 Million | - | 2.73 Million |
Inventory | -4.11 Million | -8.22 Million | -4.11 Million | 8000.00 | 4000.00 | 6.14 Million |
Other working capital | -491 Thousand | -1.75 Million | -491 Thousand | -408 Thousand | -285.5 Thousand | -731 Thousand |
Cash at beginning of period | 18.83 Million | 39.31 Million | - | 39.31 Million | - | 10.87 Million |
Cash at end of period | 31.64 Million | 31.64 Million | 3.9 Million | 18.83 Million | -6.49 Million | 31.81 Million |
Capital Expenditure | -1.02 Million | -4.04 Million | -1.02 Million | -1.99 Million | -996 Thousand | -1.95 Million |
Effect of forex changes on cash | 8000.00 | - | 8000.00 | -5500.00 | -5500.00 | -13 Thousand |
Net cash flow / Change in cash | 12.8 Million | -7.67 Million | 3.9 Million | -20.48 Million | -6.49 Million | 20.94 Million |
Free Cash Flow | -6.74 Million | -31.32 Million | -6.74 Million | -17.83 Million | -8.91 Million | -9.02 Million |
SWARNSAR
MRZ
QEM
ANL
TRIRF
EPWDF